Aurobindo Pharma Ltd. is a prominent pharmaceutical company engaged in the manufacturing and marketing of a broad range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). The primary function of Aurobindo Pharma is to supply affordable healthcare products and solutions across a variety of therapeutic categories, including antibiotics, antiretrovirals, cardiovascular products, gastroenterologicals, and central nervous system agents. Known for its comprehensive portfolio, Aurobindo serves multiple sectors by addressing the healthcare needs of both developed and emerging markets. The company plays a significant role in the global pharmaceutical industry by maintaining numerous manufacturing facilities that meet international standards, securing regulatory approvals in major markets such as the United States, Europe, and Japan. Aurobindo's R&D capabilities are notable, with a strong commitment to innovation and excellence in drug development and delivery. Established in 1986 and based in Hyderabad, India, Aurobindo Pharma Ltd. is pivotal in enhancing access to essential medicines worldwide, reflecting its market significance linked to its expansive supply chain and diverse product offerings.